A. Ramaswamy

Anant Ramaswamy, MD, Tata Memorial Hospital

Videos

Addition of Docetaxel to FOLFOX/CAPOX Backbone Fails to Improve OS in Advanced GEJ/Gastric Cancer

01/20/2024

Anant Ramaswamy, MD, discusses results from the phase 3 DOC-GC study which explored the efficacy of docetaxel added to a FOLFOX/CAPOX backbone for patients with advanced GEJ and gastric cancers.

Anant Ramaswamy, MD, discusses...

01/20/2024

Oncology

Survival outcomes and prognostic factors in high risk locally advanced rectal cancers (LARC) undergoing concurrent capecitabine and long course radiation (Cape – RT) – results of a large cohort study

BackgroundChemoradiation with Cape – RT is the standard of care in patients with LARC, though total neoadjuvant therapy might improve survival outcomes. Establishing baseline outcomes wit...

Puneet Bhargava ;

M. Reddy Yallala ;

A. Shah ;

V. Ostwal ;

A. Saklani ;

M. Kazi ;

R. Engineer ;

S. Srinivas ;

A. Ramaswamy ;

A. Ankathi ;

A. Baheti ;

06/25/2023